Home › Funds › Viking Global Investors › NAMS

Viking Global Investors position in NAMS

NEWAMSTERDAM PHARMA COMPANY · Health Care

Latest position (Q2 2026)4.20M sh
Reported value held$142.46M
Portfolio Weight0.41%
First reportedQ4 2022
Last changeHold

Quarter by quarter

QuarterSharesValueChange
Q4 2022 3.75M $39.49M New
Q1 2023 3.92M $52.63M Add
Q2 2023 6.52M $77.58M Add
Q3 2023 8.02M $74.23M Add
Q4 2023 8.02M $89.63M Hold
Q1 2024 8.02M $189.78M Hold
Q2 2024 8.02M $154.15M Hold
Q3 2024 8.02M $133.21M Hold
Q4 2024 6.98M $179.35M Reduce
Q1 2025 6.98M $142.85M Hold
Q2 2025 6.98M $126.38M Hold
Q3 2025 6.48M $184.16M Reduce
Q4 2025 4.20M $147.46M Reduce
Q1 2026 4.20M $134.56M Hold
Q2 2026 4.20M $142.46M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding NAMS

All NAMS fund holders →